23 November 2021 - The goal of much of medical research is to determine which of 2 or more therapeutic approaches ...
12 November 2021 - On 28 April 2021, the US FDA announced that it “issued its first Notice of Non-compliance to ...
9 September 2021 - In June 2021, the US FDA granted accelerated approval for aducanumab to treat patients with mild cognitive ...
3 August 2021 - To help patients with cancer learn more about how treatment may affect their quality of life, the ...
3 August 2021 - Non-adherence in a randomised clinical trial occurs when study participants do not follow the randomly assigned treatment ...
31 July 2021 - On 31 May 2021, a group of researchers and NGOs submitted an open letter to the ...
2 August 2021 - The European Commission has confirmed that the entry into application of the Clinical Trials Regulation and ...
26 July 2021 - Federal regulators have requested that vaccine companies expand their trials to test coronavirus shots in several ...
22 July 2021 - In the latest look at clinical trial transparency, a new analysis found that only 26% of ...
20 July 2021 - Medicines Australia welcomes the clinical trial ‘one-stop-shop’ consultation, recently announced by the Australian Commission on Safety ...
6 July 2021 - The Medicines and Healthcare products Regulatory Agency and Health Canada have published guidance to improve the safety ...
18 June 2021 - Data from clinical trials of three experimental Alzheimer’s disease drugs expected to start emerging next year ...
9 June 2021 - This guidance provides recommendations to sponsors for collection of a core set of patient reported clinical outcomes ...
25 May 2021 - Randomised clinical trials allocate individuals to different treatments, or, more generally, to interventions and comparators, to determine ...
20 May 2021 - This guidance represents FDA’s current thinking on adjusting for covariates in the statistical analysis of randomised clinical ...